Press release
Hims & Hers Health, Inc. (NYSE: HIMS) Investor Alert: Deadline in Lawsuit on August 25, 2025
A Deadline is coming up on August 25, 2025 in the lawsuit for certain investors in Hims & Hers Health, Inc. (NYSE: HIMS).
Investors who purchased shares of Hims & Hers Health, Inc. (NYSE: HIMS) have certain options and there are strict and short deadlines running. Deadline: HHHHH. Hims & Hers Health, Inc. (NYSE: HIMS) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges on behalf of purchasers of Hims & Hers Health, Inc. (NYSE: HIMS) common shares between April 29, 2025 and June 22, 2025, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between April 29, 2025 and June 22, 2025, the Defendants failed to disclose to investors that Hims & Hers Health, Inc. was engaged in the "deceptive promotion and selling of illegitimate, knockoff versions of Wegovy that put patient safety at risk;", that, as a result, there was a substantial risk that the Company's collaboration with Novo Nordisk would be terminated, and that, as a result of the foregoing, the Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Those who purchased shares of Hims & Hers Health, Inc. (NYSE: HIMS) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hims & Hers Health, Inc. (NYSE: HIMS) Investor Alert: Deadline in Lawsuit on August 25, 2025 here
News-ID: 4154933 • Views: …
More Releases from Shareholders Foundation, Inc.
Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potentia …
An investigation on behalf of current long-term investors in shares of Novo Nordisk A/S (NYSE: NVO) concerning potential breaches of fiduciary duties by certain directors and officers was announced.
Investors who are current long term investors in Novo Nordisk A/S (NYSE: NVO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for long term investors in…
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ …
An investor, who purchased shares of Fortinet, Inc. (NASDAQ: FTNT), filed a lawsuit over alleged violations of Federal Securities Laws by Fortinet, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fortinet, Inc. (NASDAQ: FTNT) have certain options and for certain investors are short and strict deadlines running. Deadline: November 21, 2025. NASDAQ: FTNT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on Octob …
A deadline is coming up on October 07, 2025in the lawsuit filed for certain investors of CTO Realty Growth, Inc. (NYSE: CTO) over alleged securities laws violations by CTO Realty Growth, Inc.
Investors who purchased shares of CTO Realty Growth, Inc. (NYSE: CTO) have certain options and there are strict and short deadlines running. Deadline: October 07, 2025. CTO Realty Growth, Inc. (NYSE: CTO) stockholders should contact the Shareholders Foundation at…
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeu …
An investor, who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR), filed a lawsuit over alleged violations of Federal Securities Laws by Jasper Therapeutics, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 18, 2025. NASDAQ: JSPR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Hims
Investigation announced for Investors in shares of Hims & Hers Health, Inc. (NYS …
An investigation was announced for long-term investors in shares of Hims & Hers Health, Inc. (NYSE: HIMS) concerning potential breaches of fiduciary duties by certain directors of Hims & Hers Health, Inc.
Investors who are current long term investors in Hims & Hers Health, Inc. (NYSE: HIMS) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm…
Lawsuit filed for Investors who lost money with shares of Hims & Hers Health, In …
An investor, who purchased shares of Hims & Hers Health, Inc. (NYSE: HIMS), filed a lawsuit over alleged violations of Federal Securities Laws by Hims & Hers Health, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Hims & Hers Health, Inc. (NYSE: HIMS) 25, 2025. NYSE: HIMS investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
San Francisco, CA based…
Online Medical Service Market to show Robust Growth in Upcoming Years by 2024-20 …
𝗜𝗻𝗳𝗶𝗻𝗶𝘁𝘆 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 is providing qualitative and informative knowledge by adding the title Online Medical Service Market to recognize, describe and forecast the global market. The report provides systematic consideration analysis along with forecasts for market players. The report aims to facilitate understanding of the global Online Medical Service market forecast through statistical and numerical data in the form of tables, graphs, and charts. The study provides a calculated assessment…
Hair Growth Pills Market to Witness Massive Growth by 2028 | Nutrafol, Viviscal, …
A Latest Study Released by HTF MI on the Global Hair Growth Pills Market covers key business segments and wide-scope geographies to get deep-dive analysed market data. The study is a perfect balance bridging both qualitative and quantitative information of Hair Growth Pills market. The study provides historical data (i.e. Volume** & Value) from 2018 to 2023E and forecast till 2029*. Some are the key & emerging players that are…
Online Medical Service Market May See a Big Move | Major Giants Lemonaid Health, …
SMI's latest published intelligence report "Online Medical Service Market 2023" offers in-depth market insights that assist global businesses to obtain growth opportunities. Understand how the purchase of the report can have a direct impact on your revenue. The demand for Online Medical Service is expected to upward jostle in the future with the surge in the number of Online Medical Service market players. The market is estimated to grow at…
Plus91's ABDM compliant MediXcel HIMS has successfully passed QCI and NABH audit …
Pune, India,30th January 2023 - Plus91 Technologies Pvt Ltd, a global Digital Health Solution Provider, is proud to announce that it has received the official assessment report from The Quality Council of India (QCI) and the National Accreditation Board for Hospitals and Healthcare Providers (NABH) for the HIMS Solution MediXcel. As per the report, MediXcel has successfully been audited and found compliant with all accreditation parameters for all modules and…
